Skip to main content
. 2022 Jun 23;10:778413. doi: 10.3389/fpubh.2022.778413

Table 2.

Odds of intervention receipt in COVID-19 impacted cohort vs. unaffected reference cohort at national level.

Unadjusted Adjusted
n OR 95% CI n AOR 95% CI
Women with 4+ ANC visits 1,809 1.35 [0.96–1.90] 1,809 1.53 [1.05–2.23]
Among women with any ANC:
       BP check 1,361 1.06 [0.61–1.86] 1,361 1.09 [0.61–1.93]
       Weighed 1,361 1.15 [0.71–1.89] 1,361 1.23 [0.72–2.10]
       Urine test 1,361 1.16 [0.75–1.80] 1,361 1.28 [0.80–2.06]
       Blood test 1,361 1.2 [0.81–1.78] 1,361 1.48 [0.93–2.36]
       Stool test 1,361 1.17 [0.80–1.73] 1,361 1.27 [0.83–1.95]
       Syphilis test 1,361 0.7 [0.43–1.14] 1,361 0.71 [0.43–1.17]
       HIV test 1,361 0.99 [0.63–1.55] 1,361 1.2 [0.69–2.07]
       TT shot 1,361 1.24 [0.80–1.91] 1,361 1.21 [0.77–1.90]
       IFA 1,361 1.16 [0.69–1.96] 1,361 1.26 [0.73–2.18]
       Deworming 1,361 1.4 [0.89–2.22] 1,356 1.53 [0.96–2.45]
Women that received IFA during pregnancy 1,809 1.3 [0.86–1.96] 1,809 1.49 [0.96–2.31]
Women that received deworming during pregnancy 1,809 1.4 [0.89–2.19] 1,800 1.56 [0.99–2.45]
Pregnant women that sought care for:
       Pregnancy complications 918 2.15 [1.39–3.32] 918 2.2 [1.41–3.43]
       Delivery complications 692 1.99 [1.15–3.44] 692 2.27 [1.22–4.23]
       Post-delivery complications 556 3.49 [1.89–6.45] 556 3.89 [1.95–7.77]
Women who delivered in a health facility 1,809 1.06 [0.73–1.54] 1,809 1.07 [0.66–1.75]
Among women delivering in a health facility:
       C-section 1,103 0.79 [0.40–1.56] 1,101 0.83 [0.43–1.59]
       Blood transfusion 1,103 1.63 [0.33–8.07] 702 1.38 [0.33–5.74]
       Uterotonic use 1,103 2.41 [1.09–5.34] 1,101 2.67 [1.13–6.31]
       Mother checked after birth 1,103 1.19 [0.75–1.89] 1,103 1.2 [0.75–1.93]
       Baby resuscitated with ambu bag# 43 16.69 [1.17–237.27] 33
       Chlorohexidine applied to cord stump 1,083 0.73 [0.28–1.93] 1,083 0.82 [0.31–2.13
       Baby weighed at birth 1,103 1.33 [0.76–2.34] 1,101 1.42 [0.79–2.55]
       Baby checked after birth 1,106 1 [0.60–1.68] 1,106 1.01 [0.60–1.69]
       Skin to skin 1,106 0.83 [0.46–1.51] 1,104 0.86 [0.47–1.56]
       Delayed bathing 1,106 1.66 [0.89–3.09] 1,104 1.75 [0.91–3.38]
       Early initiation of breastfeeding 1,106 0.89 [0.52–1.50] 1,104 0.97 [0.55–1.70]
Women who received a c-section 1,809 0.83 [0.43–1.57] 1,800 0.84 [0.43–1.66]
Women who received a uterotonic 1,809 1.43 [0.97–2.10] 1,809 1.63 [1.07–2.48]
Newborns who had chlorohexidine applied to stump 1,779 0.98 [0.42–2.28] 1,779 1.2 [0.50–2.88]
Newborns receiving skin to skin 1,808 0.99 [0.66–1.48] 1,808 1.04 [0.65–1.65]
Newborns with delayed bathing 1,808 1.07 [0.72–1.61] 1,808 1.14 [0.74–1.75]
Newborns with early initiation of breastfeeding 1,808 0.88 [0.63–1.24] 1,808 0.92 [0.65–1.30]
Women who received a postnatal check within 48 hrs 1,809 1.28 [0.91–1.81] 1,809 1.38 [0.94–2.02]
Newborns who received a postnatal within first 48 hrs 1,779 1.24 [0.83–1.85] 1,779 1.28 [0.83–1.98]
Home visit (or sought care) within first week 1,779 1.37 [0.84–2.24] 1,779 1.54 [0.94–2.53]
BF counseling during PNC 607 1.14 [0.63–2.07] 605 1.11 [0.61–2.02]
Newborns who received BCG vaccine* 1,808 1.67 [1.12–2.48] 1,808 2.22 [1.35–3.67]
Newborns who received polio vaccine* 1,808 1.8 [1.28–2.54] 1,808 2.19 [1.47–3.25]
Newborns exclusively breastfed* 1,761 0.94 [0.62–1.41] 1,761 1.05 [0.69–1.59]
Sought skilled care for NN illness 641 1.65 [1.00–2.72] 638 1.83 [1.07–3.11]
Women practicing family planning post-delivery* 1,809 1.74 [1.17–2.58] 1809 1.76 [1.12–2.76]
Women who intend to practice family planning in next year* 1,492 1 [0.72–1.38] 1,492 1.06 [0.73–1.53]
#

Among children in need of neonatal resuscitation based on maternal report of asphyxia at birth.

*

At time of follow-up interview.

Green shading indicates interventions with significantly greater odds of receipt in the COVID-19 cohort compared to the unaffected reference cohort.

Orange shading indicates interventions with significantly lower odds of receipt in the COVID-19 cohort compared to the unaffected reference cohort.